Takei Y - Search Results

1

Accuracy of carbohydrate-deficient transferrin as a biomarker of chronic alcohol abuse during treatment for alcoholism.

Suzuki T, Eguchi A, Shigefuku R, Nagao S, Morikawa M, Sugimoto K, Iwasa M, Takei Y. Suzuki T, et al. Among authors: takei y. Hepatol Res. 2022 Jan;52(1):120-127. doi: 10.1111/hepr.13642. Epub 2021 Apr 13. Hepatol Res. 2022. PMID: 33797850

2

Hepatic steatosis is a predictor of poor response to interferon alpha-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C.

Yaginuma R, Ikejima K, Okumura K, Kon K, Suzuki S, Takei Y, Sato N. Yaginuma R, et al. Among authors: takei y. Hepatol Res. 2006 May;35(1):19-25. doi: 10.1016/j.hepres.2006.02.001. Epub 2006 Mar 13. Hepatol Res. 2006. PMID: 16531110

3

Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells.

Fuke H, Shiraki K, Sugimoto K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Masuya M, Takei Y. Fuke H, et al. Among authors: takei y. Biochem Biophys Res Commun. 2007 Nov 23;363(3):738-44. doi: 10.1016/j.bbrc.2007.09.049. Epub 2007 Sep 21. Biochem Biophys Res Commun. 2007. PMID: 17904524

4

Hepatic intravascular large B cell lymphoma.

Shiraki K, Sugimoto K, Deguchi M, Ito N, Masuda C, Takei Y. Shiraki K, et al. Among authors: takei y. Intern Med. 2007;46(20):1761-2. doi: 10.2169/internalmedicine.46.0299. Epub 2007 Oct 15. Intern Med. 2007. PMID: 17938536 Free article. No abstract available.

5

Phytobezoars.

Beppu T, Sugimoto K, Shiraki K, Takei Y, Yoshimura H, Tagawa S. Beppu T, et al. Among authors: takei y. Intern Med. 2008;47(2):119. doi: 10.2169/internalmedicine.47.0645. Epub 2008 Jan 15. Intern Med. 2008. PMID: 18195502 Free article. No abstract available.

6

Primary biliary cirrhosis following chemotherapy for Hodgkin's lymphoma.

Yoneda K, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Fuke H, Yamamoto N, Takei Y. Yoneda K, et al. Among authors: takei y. Intern Med. 2008;47(5):419-20. doi: 10.2169/internalmedicine.47.0306. Epub 2008 Mar 3. Intern Med. 2008. PMID: 18310974 Free article.

7

Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.

Tanaka J, Sugimoto K, Shiraki K, Beppu T, Yoneda K, Fuke H, Yamamoto N, Ito K, Takei Y. Tanaka J, et al. Among authors: takei y. Intern Med. 2008;47(8):747-9. doi: 10.2169/internalmedicine.47.0653. Epub 2008 Apr 16. Intern Med. 2008. PMID: 18421192 Free article.

8

Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.

Sugimoto R, Iwasa M, Maeda M, Urawa N, Tanaka H, Fujita N, Kobayashi Y, Takeda K, Kaito M, Takei Y. Sugimoto R, et al. Among authors: takei y. Am J Gastroenterol. 2008 Jun;103(6):1413-20. doi: 10.1111/j.1572-0241.2008.01788.x. Epub 2008 May 28. Am J Gastroenterol. 2008. PMID: 18510613 Clinical Trial.

9

Protective role of interleukin-18 against Fas-mediated liver injury.

Yamamoto N, Murata K, Yoneda K, Fuke H, Yamaguchi Y, Ito K, Sugimoto K, Shiraki K, Yamanaka K, Mizutani H, Takei Y. Yamamoto N, et al. Among authors: takei y. Int J Mol Med. 2008 Jul;22(1):43-8. Int J Mol Med. 2008. PMID: 18575774

10

Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.

Fujita N, Sugimoto R, Motonishi S, Tomosugi N, Tanaka H, Takeo M, Iwasa M, Kobayashi Y, Hayashi H, Kaito M, Takei Y. Fujita N, et al. Among authors: takei y. J Hepatol. 2008 Nov;49(5):702-10. doi: 10.1016/j.jhep.2008.05.014. Epub 2008 Jun 6. J Hepatol. 2008. PMID: 18620776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,571 results

Search Page